Detalles de la búsqueda
1.
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 28(3): 239-245, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36427017
2.
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
Oncologist
; 28(12): 1072-1078, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285524
3.
Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease.
Oncologist
; 27(8): 685-693, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35443042
4.
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Cancer
; 127(12): 1974-1983, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33760232
5.
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(10): e1742-e1750, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34156726
6.
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(5): 397-405, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634507
7.
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(12): 1017-1025, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34342095
8.
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
Cancer
; 126(3): 575-582, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31648379
9.
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 25(3): e484-e491, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162798
10.
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
Oncologist
; 25(3): e528-e535, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162807
11.
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
Cancer
; 125(1): 127-134, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30329148
12.
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
Invest New Drugs
; 37(6): 1198-1206, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30725388
13.
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
BMC Cancer
; 19(1): 857, 2019 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464611
14.
Reply to Body fat indices and survival in immunotherapy-treated patients with cancer.
Cancer
; 126(13): 3157-3159, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32286681
15.
Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.
Urol Oncol
; 41(1): 50.e19-50.e26, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36280529
16.
African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center.
Leuk Lymphoma
; 63(9): 2094-2101, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35481397
17.
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.
Front Endocrinol (Lausanne)
; 13: 779915, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35392134
18.
Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma.
Data Brief
; 45: 108724, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36426052
19.
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
Clin Genitourin Cancer
; 20(1): 53-59, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34922840
20.
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
J Immunother Precis Oncol
; 5(3): 52-57, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36034580